Trial ID or NCT#

NCT04268316

Status

not recruiting iconNOT RECRUITING

Purpose

The primary purpose of this study is to test the safety and feasibility of virtual reality (VR) technology in the use of behavioral activation (BA) as a treatment for major depressive disorder (MDD). The secondary purpose of this study is to examine whether any evidence of clinical efficacy exists for VR delivered BA.

Official Title

Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Kim Bullock, MD
Kim Bullock, MD
Psychiatrist, Neuropsychiatrist, Psychotherapist
Clinical Professor, Psychiatry and Behavioral Sciences

Contact us to find out if this trial is right for you.

CONTACT

Margot Paul, M.S.
(415) 625-3127